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sevier Taiwan LLC. Open access under CSummary Background: Conventional monopolar radiofrequency ablation (RFA) bears the
risks of incomplete ablation and tumor seeding. This study aimed to evaluate the effectiveness
and safety of multipolar RFA with non-touch technique for hepatocellular carcinoma (HCC)
 3 cm.
Methods: Fifteen cirrhotic patients (9 men, 6 women; age 51e83 years, mean 64.4 years,
Child-Pugh score: AZ 10 and BZ 5) with 17 HCCs of  3 cm (mean: 26 mm), which were diag-
nosed based on typical radiologic findings were enrolled. Two or three Celon Prosurge Bipolar
electrodes with 3-cm active tip were deployed with non-touch technique via percutaneous
approach under ultrasound guidance.
Results: Complete ablation was achieved in all 17 lesions. This is defined as no enhanced part
around the ablated index tumors according to dynamic computed tomography or magnetic
resonance imaging at least 1 month after ablation. No local tumor progression was detected
at follow-up (range, 3e21.5 months; mean, 10 months). No track seeding was observed. There
was one distant recurrence 15.4 months after ablation. One patient had procedure-related
biliary stricture and died of pneumonia 3.5 months after tumor ablation.Hepatology, Department of Gastroenterology and Hepatology, Chang-Gung Memorial Hospital,
nship, Taoyuan County 33305, Taiwan.
gmh.org.tw (S.-M. Lin).
3.09.004
stroenterological Society of Taiwan and The Digestive Endoscopy Society of Taiwan. Published by
C BY-NC-ND license.
Multipolar radiofrequency ablation for hepatoma 81Conclusion: Multipolar RFA with non-touch technique is an effective method to achieve com-
plete tumor ablation and an adequate safety margin. This method has low complication rate
and bears minimal risk of tumor seeding.
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Radiofrequency ablation (RFA) is an effective and safe
curative therapy used to treat small hepatocellular carci-
noma (HCC) [1,2]. However, a higher local recurrence rate
than surgical resection and the risk of tumor seeding after
ablation are major drawbacks of this procedure [3].
Conventionally, monopolar electrode is deployed into the
tumor and the ablation process is executed from the center
to the periphery. The difficulty in ensuring an adequate
safety margin when using this method is the main reason for
treatment failure and contributes to both local tumor
growth and distant recurrence.
Bipolar electrodes are devices with particular physical
characteristics. The radiofrequency (RF) current could flow
between each pole of the electrodes if the interelectrode
distance is  3 cm [4,5]. This differs from the switch control
monopolar devices, in which individual electrodes work
independently rather than simultaneously, as in bipolar
devices. In bipolar devices, six and 15 RF current directions
are enabled by the deployment of two and three elec-
trodes, respectively. This distinct characteristic allows the
electrodes to be placed close to the outer margin of the
tumor and ablate the tumor from the periphery to the
center. Hence, ablation could be performed without
touching the tumor itself. Using this method, complete
tumor ablation in the interelectrode space can be ensured.
In addition to performing ablation in the interelectrode
space, ablation could be extended to a distance of
0.5e1 cm outside the interelectrode space. This charac-
teristic allows the safety margin to be guaranteed.
Tumor seeding along the puncture route is another
concern when using monopolar RFA [6e8]. Although the
complication rate can be lowered by track ablation, the
non-touch technique can completely avoid this treatment
related complication by circumventing direct puncture of
the tumor.
A French study, using the non-touch technique for HCC
ablation, demonstrated excellent local tumor control, evi-
denced by pathological assessment of the explanted livers.
By contrast, more than half of the explanted livers that had
been previously ablated using a monopolar device remained
positive for residual tumors [9].
In this prospective study, we present the preliminary
results of the novel ablation method for HCC  3 cm.
Materials and methods
Fifteen cirrhotic patients (ChildePugh score: A or B) with 17
HCCs were enrolled in this study between October 2010 and
March 2013. All 15 patients had chronic hepatitis B (CHB),
chronic hepatitis C (CHC), or both. The diagnosis of cirrhosiswas based on ultrasound and clinical findings such as esoph-
ageal varices, gastric varices, ascites, thrombocytopenia,
and coagulopathy. The diagnosis of HCCwas based on typical
radiologic findings, which were determined according to
AASLD guidelines [10]. None of the patients received liver
biopsies because the aim of the non-touch technique was to
prevent tumor seeding during the procedure.
All procedures were performed by one physician with 4
years’ experience in performing ultrasound-guided liver
tumor ablations. All procedures were executed in the
operation room under general anesthesia. Airway protec-
tion was ensured by endotracheal tube placement. Toshiba
Xario XG (Toshiba, Tokyo, Japan) ultrasound was used for
ablation guidance.
Celon Prosurge Bipolar electrodes (Celon, Teltow, Ger-
many) with 3 cm active tip were deployed. These electrodes
are 1.8 mm in diameter and 15 cm or 20 cm in total needle
length. The electrodes were used with coolant pump to have
internal cooling. No grounding pads were needed with this
device. Two or three electrodes were deployed according to
the tumor size and location. Most ablation procedures were
performed with the free-hand technique. The energy output
was adjusted during the ablation process, according to the
formation of air bubbles, as shown on the ultrasoundmonitor
and by automated resistance and impedance calculation
software. Ablation was considered complete based on 2 pa-
rameters. The first parameter was continuous air bubble
formation in the interelectrode spaceand in theouter areaof
the electrodes. The secondparameterwas the formation of a
ladder-like form on the panel indicating resistance profiles.
The draw-back technique was applied to ensure adequate
ablation depth and safety margin. Needle track ablation was
done during every electrode withdrawal with 40 W energy
output to prevent bleeding and unexpected tumor seeding.
Artificial ascites or pleural effusion or both were created
by infusion of 5% dextrose water if the tumors were close to
other organs such as the diaphragm, bowel, or kidney.
Four-phase computed tomography (CT) scan or dynamic
magnetic resonance imaging (MRI) of the liver were con-
ducted 1 month after tumor ablation. Complete tumor
ablation was defined by the absence of an enhanced region
within or adjacent to the ablated index tumor. Distant and
local tumor recurrence were monitored using ultrasound
examinations every 3 months and CT/MRI every 6 months.
Results
Patient characteristics
Nine men and six women were enrolled in this study. The
patients’ age ranged from 51 years to 83 years, with a mean
of 64.4 years. Nine of the fifteen patients (60%) were
82 L.-W. Wu et al.diagnosed with CHC, four with CHB (26.7 %), and two with
both CHB and CHC (13.3%). Five of the 15 patients had
received antiviral therapy; the patients who had not
received antiviral therapy all had CHC, and were precluded
from treatment because of old age and potential intoler-
ance of treatment-related adverse effects.
Two patients exhibited two lesions: a 60-year-old man
with CHC exhibited a 20-mm lesion in Segment 4 and a 30-
mm lesion in Segment 5; and a 51-year-old man with CHB
exhibited two 16-mm lesions in Segments 5 and 8,
respectively.
The 17 tumors ranged from 14 mm to 30 mm, and the
mean diameter was 26 mm. Three were located in Segment
4, five in Segment 5, one in Segment 6, three in Segment 7,
and five in Segment 8.
The demographic characteristics of the patients are lis-
ted in Table 1.
Ablation process and technique
Five of the seventeen lesions were ablated using only two
electrodes because of difficulty in placing three electrodes
simultaneously. Artificial ascites or pleural effusion were
produced for six tumors, of which five were located in the
subphrenic area, and one was located close to the right
kidney.
The ablation time ranged from 10.2 minutes to 33.3
minutes, and the mean ablation time was 18.5 minutes. The
total energy deposition ranged from 25.0 kJ to 111.6 kJ,
and the mean energy deposition was 52.1 kJ.
When all electrodes were withdrawn, track ablation was
performed using a 40-W energy output to form a “comet-
tail” appearance along the needle route on the ultrasound
monitor.
Photographs of the non-touch technique and track
ablation are presented in Figs. 1 and 2, respectively.
Local tumor control
Successful local tumor control was defined by the absence
of an enhanced region within or around the ablated areas
on CT or MRI images 1 month and every 6 months after the
procedure. All of the 17 index tumors met the criteria, and
a 0.5e1-cm safety margin was achieved around each tumor.
The maximal, minimal, and mean follow-up periods were
21.5 months, 3 months, and 10 months, respectively.Table 1 Baseline characteristics of the 15 patients.
Characteristics
Age (y) 64.4  11.8
Sex, male 9 (60%)
CHB/CHC/CHB and CHC 9/4/2
CTP score: A/B 10 (67%)/5 (33%) (all < CTP: 8)
Tumor size (mm) 26.0  3.7
Tumor location
(Seg 4/5/6/7/8)
3/5/1/3/5
AFP (ng/mL) 51.2  39.2
AFP Z a-fetoprotein; CHB Z chronic hepatitis B;
CHC Z chronic hepatitis C; CTP score Z ChildeTurcotteePugh
score.Distant recurrence
There was only one instance of distant recurrence, 15.4
months after initial ablation in a 60-year-old man. The
initial two ablated index tumors were located in Segments 4
and 5, and were 2 cm and 3 cm in diameter, respectively.
The distant recurrence, which occurred in Segment 2, was
2 cm in diameter.
Complications
Most patients experienced mild puncture wound pain,
which subsided gradually. One patient experienced pro-
found jaundice 3 months after the procedure; a CT scan
revealed left biliary tree dilation, and postprocedure
fibrosis-related biliary stricture was assumed to be the
cause.
Discussion
To our knowledge, this is the first report to use the non-
touch technique to treat HCC in Taiwan. This new method
overcomes the shortcomings of current ablation tech-
niques, including inadequate safety margins, the difficulty
of ablating larger tumors, the heat-sink effect, and track
seeding. By addressing these shortcomings, our study
demonstrated that multipolar RFA achieves excellent local
tumor control, eliminates the risk of track seeding, and
presents a minimal risk of distant recurrence.
RFA is an effective method to treat small HCC, particu-
larly in patients with cirrhosis, because surgical resection
might be precluded in certain patients because of comor-
bidities [11]. However, most studies have observed that RFA
presents a higher risk of tumor recurrence compared with
surgical resection; incomplete local tumor control and
inadequate safety margins in studies using RFA might
explain why RFA exhibits worse disease-free survival and
overall survival rates than surgical resection does. Two re-
ports from Korea have indicated that a 1-cm safety margin
is crucial to ensure complete tumor ablation and to reduce
the risk of local tumor progression [12,13]. The basic
physical characteristics of monopolar devices require that
the tumor is punctured by the electrode, and that the
ablation process is initiated from the tumor center to the
periphery. As a consequence, a 0.5e1-cm safety margin is
difficult to obtain using this device. By using two or three
electrodes to puncture the area around the tumor, multi-
polar RFA extends the ablation zone to obtain a minimal
0.5-cm safety margin easily.
Most monopolar electrodes are able to obtain ablation
diameters of 3 cm, or slightly larger. Sequential overlapping
ablation to enable a larger ablation zone when using
monopolar devices is difficult, because air bubbles created
during ablation can hamper the visualization of subsequent
electrode deployment. Using the non-touch technique and
multipolar electrodes, complete ablation can be easily
achieved once the electrodes are placed in the appropriate
locations.
Another shortcoming of monopolar devices is the pres-
ence of the heat-sink effect if the index tumor is close to a
large vessel (> 3 mm) [14,15]. Using multipolar devices
Figure 1 (A) One 2 cm HCC in the S7. (B) Three electrodes (white arrows) were deployed around the tumor (red arrow). The third
electrode was not shown in this plane. (C) The deployment of three electrodes to encircle the tumor. (D) CT of liver, 6 months after
ablation, showed complete ablation with 1 cm safety margin. (E) Ladder-like appearance of the resistance profile on monitor of
energy generator indicating completion of ablation.
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index tumor, and complete ablation to be obtained in the
interelectrode space. Therefore, the heat-sink effect can
be overcome by using this method.
Track seeding is always a concern in percutaneous liver
interventions such as liver biopsies or RFA. Tumor seeding
after percutaneous RFA, with an occurrence rate as high as
12.5 % (4 of 32 cases), was reported by Llovet et al [16] in
2001. In another study from Taiwan, a 1.2 % track-seeding
rate was reported [17]. These various seeding rates might
be related to follow-up duration, the number of ablation
sessions, whether tumor biopsies had been performed prior
to RFA, and the completeness of the track ablation. In our
study, no track seeding was observed during the follow-up
period. Two reasons might account for this successful
result. The most critical reason is the use of the non-touch
approach: by avoiding contact with the tumor itself, the
adherence of tumor cells to the electrodes was reduced,
and track seeding during the advance and retraction of theelectrodes was prevented. The second reason is that track
ablation was strictly performed using a 40-W energy output.
During each electrode retraction, we created a “comet-
tail” image along the track on the ultrasound monitor.
Hence, in the following spiral CT or MRI, the evident track
ablation route can be clearly seen.
An increased number of RF probe punctures increases
the risk of damage to adjacent organs, and increases the
need for artificial ascites or pleural effusion. Artificial as-
cites or pleural effusion were created in six patients
because the locations of their index tumors were difficult to
operate on; five of these six tumors were in the subphrenic
area, and one was located close to the right kidney. Five
patients with subphrenic tumors received concomitant
artificial ascites and pleural effusions. One patient with an
S6 tumor received only artificial ascites. The mean artificial
ascites volume was 1200 mL and the maximal volume was
3000 mL. The mean artificial pleural effusion volume was
500 mL. The introduction of artificial ascites and pleural
Figure 2 (A) Track ablation under 40 W energy output to
form “Comet tail” appearance. (B) Evident track ablation
shown in the following MRI.
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the adjacent diaphragm or right kidney. Most of the injec-
ted artificial ascites and pleural effusion were absorbed
spontaneously the day after the procedure. Artificial asci-
tes and pleural effusion also allowed the index tumor to be
visualized more clearly.
Despite the use of artificial ascites and pleural effusion,
three electrodes could not be simultaneously placed when
treating one third of the tumors in our study (5/17) because
of the problematic locations of the index tumors and the
narrow echo-window. In these cases, only two electrodes
were applied. All of these tumors were < 2 cm. However, it
seems that two electrodes were adequate, because the
rate of complete tumor ablation was determined to be 100%
in the short-term follow-up period.
The only procedure-related complication in our study
occurred 3 months after tumor ablation. A patient pre-
sented with profound jaundice and the spiral CT showed
that the left intrahepatic ducts were substantially dilated,
and the total bilirubin level was 30 mg/dL. The ablated
index tumor was located in Segment 4 and was approxi-
mately 3 cm in diameter. The tumor was ablated using
three electrodes, and the patient was uneventful during
and immediately after the procedure. We assumed that
postprocedure fibrosis led to the stricture of the left biliary
tract. Direct thermal injury to the bile duct during theprocedure was assumed to be unlikely, because the elec-
trodes were 1.5 cm away from the left portal vein,
considered a marker for the major left biliary tract; the bile
duct was therefore beyond the ablation ability of the
multipolar device. A biliary stent and external drainage was
used to treat the obstructive jaundice. However, the pa-
tient died of pneumonia 2 weeks after the onset of pro-
found jaundice. Therefore, we used prophylactic biliary
stenting to treat patients with index tumors close to major
bile ducts (n Z 4) thereafter, and no further biliary com-
plications occurred.
Certain points deserve mention. First, in Taiwan, most
ultrasound-guided interventions are performed with the
assistance of a puncture probe. However, it is relatively
difficult to insert three electrodes in the narrow echo-
window and the limited treatment area on the abdominal
wall because the large size of the puncture probe might
impede the operation of the electrodes. In this situation,
the free-hand technique is required to place the three
electrodes in parallel, to allow each electrode to interact
with other electrodes and function effectively. Therefore,
an aseptic ruler and surgical mark-pen are useful to deploy
electrodes properly. Second, the non-touch technique and
multiple electrodes deployment require a longer proce-
dural time and operator learning curve. Third, the cost of
the electrodes must be considered.
This study has certain limitations. First, the follow-up
period was not adequate to assess disease-free survival or
overall survival. Second, a larger sample is necessary to
obtain a more solid conclusion regarding this technique.
In summary, multipolar RFA using the non-touch tech-
nique to treat HCCs  3 cm is an effective and safe method.
This promising ablation method yielded excellent local
tumor control with low complication rates. Track seeding
was also eliminated using the new concept. However,
assessing long-term results regarding disease-free survival
and overall survival requires a longer follow-up time.Conflicts of interest
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